edgen-logo

AI Copilot
portfolioPortfolio

Stocks

Crypto

News
StocksCrypto

Chat History

Aura
Follow our

Join our

EN
Back

Oral GLP-1 Race Intensifies as Novo Nordisk Awaits Key FDA Decision
Stock NewsThemesOral GLP-1 Race Intensifies as Novo Nordisk Awaits Key FDA Decision

Oral GLP-1 Race Intensifies as Novo Nordisk Awaits Key FDA Decision

Edgen StockEdgen Stock·Sep 12 2025, 00:19
Share to
Share to
Copy link
NVONVO+1.00%LLYLLY+1.43%
Oral GLP-1 Race Intensifies as Novo Nordisk Awaits Key FDA Decision
source:
[1] 1 Reason Every Investor Should Know About Novo Nordisk (NVO) | The Motley Fool (https://www.fool.com/investing/2025/09/08/1-r ...)[2] Novo Nordisk's Oral Weight Loss Pill: A Game-Changer in the $150B Obesity Market (https://vertexaisearch.cloud.google.com/groun ...)[3] Lilly shares fall as obesity pill misses expectations in key trial - BioPharma Dive (https://vertexaisearch.cloud.google.com/groun ...)

Related News

Babcock & Wilcox Secures $40M Refinery Contract
Dec 19 2025, 22:38

Babcock & Wilcox Secures $40M Refinery Contract

Babcock & Wilcox announced on December 19, 2025, that it secured a $40 million contract to supply its Wet Gas Scrubbing technology to a Canadian petroleum refinery, major Canadian petroleum refinery.

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales
Dec 19 2025, 22:29

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales

A Yale study finds Elon Musk's political stance cost Tesla 1.26 million car sales, contributing to a profit drop to $7.1 billion in 2024 from $15 billion in 2023.

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes
Dec 19 2025, 22:27

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes

On December 16, Mizuho increased its price target for Tesla to $530, citing growing confidence in the automaker's future robotaxi business.